Skip to main content
. 2016 Aug 24;1(4):299–305. doi: 10.1016/j.ekir.2016.08.012

Table 6.

Clinical outcome by treatment

Treatment Complete Remission Partial remission Persistent disease ESRD
None (n = 3) 1 2 0 0
RAS blockade alone (n = 6) 3 0 3 0
Immunosuppression (n = 15) 7 2 6 0
None; ESRD on presentation (n = 3) 0 0 0 3

ESRD, end-stage renal disease; RAS, renin−angiotensin system.